NAV as on 29-04-2025
AUM as on
Rtn ( Since Inception )
22.2%
Inception Date
Feb 06, 2024
Expense Ratio
2.37%
Fund Status
Open Ended Schemes
Min. Investment
100
Min. Topup
100
Min. SIP Amount
100
Risk Status
very high
Investment Objective : The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.